Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications

Reviews in Endocrine and Metabolic Disorders

Volumn 18, Issue 3, 2017, Pages 307-322

  Wagner, Carol L ^a   Hollis, Bruce W ^a   Kotsa, Kalliopi ^b   Fakhoury, Hana ^c   Karras, Spyridon N ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Asthma; Cholecalciferol; Complications of pregnancy; Health outcomes; Lactation; Preeclampsia; Pregnancy; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ASTHMA; AUTOIMMUNITY; CALCIUM HOMEOSTASIS; CHILDHOOD DISEASE; DRUG EFFECT; HEALTH STATUS; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NEWBORN DISEASE; OBSERVATIONAL STUDY; PERINATAL PERIOD; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; DIETARY SUPPLEMENT; FEMALE; NEWBORN; PRENATAL EXPOSURE; PREVENTION AND CONTROL;

DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85013080743     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-017-9414-3     Document Type: Review

References (100)

1. Hollis B, Wagner C. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr. 2004;79:717–26.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; doi:10.1210/jc.2011-0385.
3. Camargo Jr CA, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011;127(1):e180–e7.
4. Litonjua AA. Childhood asthma may be a consequence of vitamin D deficiency. Curr Opin Allergy Clin Immunol. 2009;9(3):202–7.
5. Munger KL, Aivo J, Hongell K, Soilu-Hanninen M, Surcel HM, Ascherio A. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish maternity cohort. JAMA Neurol. 2016;73(5):515–9.
6. Greenberg BM, Vitamin D. During pregnancy and multiple sclerosis: an evolving association. JAMA Neurol. 2016;73(5):498–9.
7. Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013;84(4):427–32.
8. Berlanga-Taylor AJ, Disanto G, Ebers GC, Ramagopalan SV. Vitamin D-gene interactions in multiple sclerosis. J Neurol Sci. 2011;311(1–2):32–6.
9. Ebers G. Interactions of environment and genes in multiple sclerosis. J Neurol Sci. 2013;334(1–2):161–3.
10. Stubbs G, Henley K, Green J. Autism: will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med Hypotheses. 2016;88:74–8.
11. McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry. 2010;67(9):889–94.
12. Cannell JJ. Autism and vitamin D. Med Hypotheses. 2008;70(4):750–9.
13. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW. Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol. 2004;89–90(1–5):557–60.
14. Hacker AN, Fung EB, King JC. Role of calcium during pregnancy: maternal and fetal needs. Nutr Rev. 2012;70(7):397–409.
15. Shao H, Tao M, Fan Y, Jing J, Lu J. Vitamin D levels and other factors related to bone mineral density during pregnancy. Aust N Z J Obstet Gynaecol. 2012;52(6):571–5.
16. Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Annu Rev Nutr. 2012;32(1):97–123.
17. Karras SN, Anagnostis P, Bili E, Naughton D, Petroczi A, Papadopoulou F, et al. Maternal vitamin D status in pregnancy and offspring bone development: the unmet needs of vitamin D era. Osteoporos Int. 2014;25(3):795–805.
18. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984;74(6):1966–71.
19. Kumar R, Cohen WR, Silva P, Epstein FH. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest. 1979;63(2):342–4.
20. Lund B, Selnes A. Plasma 1,25-dihydroxyvitamin D levels in pregnancy and lactation. Acta Endocrinol. 1979;92(2):330–5.
21. Steichen J, Tsang R, Gratton T, Hamstra A, DeLuca H. Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. N Engl J Med. 1980;302(6):315–9.
22. Seino Y, Ishida M, Yamaoka K, Ishii T, Hiejima T, Ikehara C, et al. Serum calcium regulating hormones in the perinatal period. Calcif Tissue Int. 1982;34(2):131–5.
23. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87(6):1738–42.
24. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2011;26(10):2341–57.
25. Walker VP, Zhang X, Rastegar I. Liu PT. Adams JS, et al. Cord Blood Vitamin D Status Impacts Innate Immune Responses. J Clin Endocrinol Metab: Hollis BW; 2011.
26. Eichholzer M, Platz EA, Bienstock JL, Monsegue D, Akereyeni F, Hollis BW, et al. Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes Control. 2013;24(1):91–8.
27. Carneiro RM, Prebehalla L, Tedesco MB, Sereika SM, Hugo M, Hollis BW, et al. Lactation and bone turnover: a conundrum of marked bone loss in the setting of coupled bone turnover. J Clin Endocrinol Metab. 2010;95(4):1767–76.
28. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol. 1981;77(1):51–8.
29. 3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption. Gut. 1978;19:267–72.
30. Hollis BW, Lowery JW, Pittard 3rd WB, Guy DG, Hansen JW. Effect of age on the intestinal absorption of vitamin D3-palmitate and nonesterified vitamin D2 in the term human infant. J Clin Endocrinol Metab. 1996;81(4):1385–8.
31. Heubi JE, Hollis BW, Specker B, Tsang RC. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology. 1989;9(2):258–64.
32. Haddad JG, Matsuoka LY, Hollis BW, Hu Y, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest. 1993;91(6):2552–5.
33. Ponchon G, Kennan AL, DeLuca HF. "activation" of vitamin D by the liver. J Clin Invest. 1969;48(11):2032–7.
34. Flanagan JN, Young MV, Persons KS, Wang L, Mathieu JS, Whitlatch LW, et al. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res. 2006;26(4A):2567–72.
35. Karlgren M, Miura S, Ingelman-Sundberg M. Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol. 2005;207(2 Suppl):57–61.
36. Hosseinpour F, Wikvall K. Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. J Biol Chem. 2000;275(44):34650–5.
37. Schuessler M, Astecker N, Herzig G, Vorisek G, Schuster I. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D(3): CYP27 in epidermis completes the set of essential vitamin D(3)-hydroxylases. Steroids. 2001;66(3–5):399–408.
38. Zhu J, DeLuca HF. Vitamin D 25-hydroxylase - four decades of searching, are we there yet? Arch Biochem Biophys. 2012;523(1):30–6.
39. Smith JE, Goodman DS. The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest. 1971;50(10):2159–67.
40. Bouillon R, van Baelen H, de Moor P. Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem. 1980;13(9):1029–34.
41. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalceferol, cholecaliferol and their major metabolites. J Steroid Biochem. 1984;21:81–6.
42. Kissmeyer A, Mathiasen IS, Latini S, Binderup L. Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine. 1995;3(4):263–6.
43. Vieth R, Kessler MJ, Pritzker KP. Species differences in the binding kinetics of 25-hydroxyvitamin D3 to vitamin D binding protein. Can J Physiol Pharmacol. 1990;68(10):1368–71.
44. Haddad JG, Hillman L, Rojanasathit S. Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1976;43(1):86–91.
45. Marzolo MP, Farfan P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res. 2011;44(1):89–105.
46. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96(4):507–15.
47. Rasmussen H, Wong M, Bikle D, Goodman DB. Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest. 1972;51(9):2502–4.
48. Akour AA, Gerk P, Kennedy MJ. Megalin expression in human term and preterm placental villous tissues: effect of gestational age and sample processing and storage time. J Pharmacol Toxicol Methods. 2015;71:147–54.
49. Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res. 2007;24(9):1759–71.
50. Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239.
51. 3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology. 2008;149(7):3656–67.
52. Bodnar LM, Simhan HN, Catov JM, Roberts JM, Platt RW, Diesel JC, et al. Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology. 2014;25(2):207–14.
53. Robinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol. 2010;203(4):366 e1–6.
54. Liu NQ, Ouyang Y, Bulut Y, Lagishetty V, Chan SY, Hollis BW, et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology. 2013;154(7):2270–80.
55. Faulkner JL, Cornelius DC, Amaral LM, Harmon AC, Cunningham Jr MW, Darby MM, et al. Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2015; doi:10.1152/ajpregu003882015.
56. Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One. 2015;10(11):e0141770.
57. Hollis BW, Wagner CL. Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98(12):4619–28.
58. McGrath JJ, Eyles DW, Pedersen CB, Anderson C, Ko P, Burne TH, et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry. 2010;67(9):889–94.
59. LaMarca B, Amaral LM, Harmon AC, Cornelius DC, Faulkner JL, Cunningham Jr MW. Placental ischemia and resultant phenotype in animal models of preeclampsia. Curr Hypertens Rep. 2016;18(5):38.
60. Gibson CC, Davis CT, Zhu W, Bowman-Kirigin JA, Walker AE, Tai Z, et al. Dietary vitamin D and its metabolites non-Genomically stabilize the endothelium. PLoS One. 2015;10(10):e0140370.
61. Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, et al. Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation. 2015;131(3):289–99.
62. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517–22.
63. Baker AM, Haeri S, Camargo Jr CA, Espinola JA, Stuebe AM. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab. 2010;95(11):5105–9.
64. Gernand AD, Bodnar LM, Klebanoff MA, Parks WT, Simhan HN. Maternal serum 25-hydroxyvitamin D and placental vascular pathology in a multicenter US cohort. Am J Clin Nutr. 2013;98(2):383–8.
65. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009;94(3):940–5.
66. Zhang C, Qiu C, Hu FB, David RM, van Dam RM, Bralley A, et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One. 2008;3(11):e3753.
67. Bodnar LM, Simhan HN. Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv. 2010;65(4):273–84.
68. Qin LL, Lu FG, Yang SH, Xu HL, Luo BA. Does Maternal Vitamin D Deficiency Increase the Risk of Preterm Birth: A Meta-Analysis of Observational Studies. Nutrients. 2016;8(5) doi:10.3390/nu8050301.
69. Mirzakhani H, Litonjua AA, McElrath TF, O'Connor G, Lee-Parritz A, Iverson R, et al. Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest. 2016; doi:10.1172/JCI89031.
70. Mirzakhani H, Litonjua A, Sharma A, Laranjo N, Harshfield BJ, Carey VJ, et al., editors. Higher vitamin D levels in early pregnancy and risk of preeclampsia. The Vitamin D Workshop; 2016 March 29–31, 2016; Boston, MA: http://www.vitamindworkshop.org/.
71. Robinson CJ, Wagner CL, Hollis BW, Baatz JE, Johnson DD. Maternal vitamin D and fetal growth in early-onset severe preeclampsia. Am J Obstet Gynecol. 2011; doi:10.1016/j.ajog.2011.03.022.
72. Bodnar LM, Platt RW, Simhan HN. Early-Pregnancy Vitamin D Deficiency and risk of preterm birth subtypes. Obstet Gynecol. 2015; doi:10.1097/AOG.0000000000000621.
73. Bowyer L, Catling-Paull C, Diamond T, Homer C, Davis G, Craig ME. Vitamin D, PTH and calcium levels in pregnant women and their neonates. Clin Endocrinol. 2009;70(3):372–7.
74. Burris HH, Rifas-Shiman SL, Camargo Jr CA, Litonjua AA, Huh SY, Rich-Edwards JW, et al. Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants. Ann Epidemiol. 2012; doi:10.1016/j.annepidem.2012.04.015.
75. Mojibian M, Soheilykhah S, Fallah Zadeh MA, Jannati MM. The effects of vitamin D supplementation on maternal and neonatal outcome: a randomized clinical trial. Iran J Reprod Med. 2015;13(11):687–96.
76. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72(1):48–54.
77. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F, et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab. 2001;86(7):3086–90.
78. Vieth R. Vitamin D supplementation, 25-hydroxy-vitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–56.
79. Heaney R, Davies K, Chen T, Holick M, Barger-Lux M. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204–10.
80. Hollis BW, Wagner CL. Vitamin d and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int. 2013;92(2):128–39.
81. Wagner CL, McNeil RB, Johnson DD, Hulsey TC, Ebeling M, Robinson C, et al. Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J Steroid Biochem Mol Biol. 2013;136:313–20.
82. Wagner CL, Baggerly C, McDonnell S, Baggerly KA, French CB, Baggerly L, et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009–2011 rates. J Steroid Biochem Mol Biol. 2016;155(Pt B):245–51.
83. Goldring ST, Griffiths CJ, Martineau AR, Robinson S, Yu C, Poulton S, et al. Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS One. 2013;8(6):e66627.
84. Sablok A, Batra A, Thariani K, Batra A, Bharti R, Aggarwal AR, et al. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome. Clin Endocrinol. 2015;83(4):536–41.
85. Chawes BL, Bonnelykke K, Stokholm J, Vissing NH, Bjarnadottir E, Schoos AM, et al. Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial. JAMA. 2016;315(4):353–61.
86. Litonjua AA, Carey VJ, Laranjo N, Harshfield BJ, McElrath TF, O'Connor GT, et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 Years: the VDAART randomized clinical trial. JAMA. 2016;315(4):362–70.
87. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009;179(9):765–71.
88. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the childhood asthma management program study. J Allergy Clin Immunol. 2010;126(1):52–8. e5
89. Weiss S, Wolsk H, Mirzakhani H, Hollis B, Carey V, Litonjua A, et al., editors. Asthma/Wheeze and preeclampsia outcomes in the VDAART Trial: The influcence of baseline and treatment levels of vitamin D on treatment response. The Vitamin D Workshop; 2016 March 29–31, 2016; Boston, MA: http://www.vitamindworkshop.org/.
90. Mirzakhani H, Harshfield B, Carey V, Laranjo N, Litonjua A, Weiss S, editors. Association of maternal asthma and early pregnancy serum vitamin D level with risk of preeclampsia. The Vitamin D Workshop. 29–31, 2016. Boston: MA ; 2016 March.http://www.vitamindworkshop.org/
91. Wolsk H, Harshfield BJ, Laranjo N, Carey V, Weiss S, editors. Vitamin D supplementation in pregnant women of different races and the risk of asthma/recurrent wheeze in the child: findings from the vitamin D antenatal asthma reduction trial (VDAART). The Vitamin D Workshop; 2016 March 29–31, 2016; Boston, MA: http://www.vitamindworkshop.org/.
92. Wolsk H. Personal communication: meta-analysis of vitamin D pregnancy supplementation RCT 3-yr asthma and wheezing risks. Hollis B, editor: In; 2016.
93. Zhu H, Wagner C, Pan Y, Wang X, Shary J, Hollis B, et al., editors. Maternal vitamin D supplementation and cord blood genome-wide DNA methylation analysis. (abstract). Vitamin D Workshop; 2016 March 29–31, 2016; Boston, MA: http://www.vitamindworkshop.org/; 2016.
94. Schulz E, Cruze L, Wei W, Garrett-Meyer E, Shary J, Forestieri N, et al., editors. Effects of maternal vitamin D supplementation on placental gene expression (platform presentation). Pediatric Academic Societies; 2016 April 30–may 3, 2016; Baltimore, MD: Pediatric Academic Societies.
95. Kiely M, Zhang J, Kinsella M, Khashan A, Kenny L, editors. Vitamin D status is associated with utero-placental dysfunction in a large prospective pregnancy cohort with low 25(OH)D3 and ubiquitous 3-epi-25(OH)D3 and 25(OH)D3 and 25(OH)D2. The Vitamin D Workshop; 2016 May 29–31, 2016; Boston, MA: http://www.vitamindworkshop.org/.
96. Whitehouse AJ, Holt BJ, Serralha M, Holt PG, Kusel MM, Hart PH. Maternal serum vitamin d levels during pregnancy and offspring neurocognitive development. Pediatrics. 2012;129(3):485–93.
97. Hollis BW, Wagner CL. The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98(12):4619–28.
98. Karras SN, Fakhoury H, Muscogiuri G, Grant WB, van den Ouweland JM, Colao AM, et al. Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications. Ther Adv Musculoskelet Dis. 2016;8(4):124–35.
99. Karras SN, Anagnostis P, Naughton D, Annweiler C, Petroczi A. Goulis DGVitamin D during pregnancy: why observational studies suggest deficiency and interventional studies show no improvement in clinical outcomes? A narrative review. J Endocrinol Investig. 2015;38(12):1265–75.
100. Karras SN, Anagnostis P, Petroczi A, Annweiler C, Naughton DP. Goulis DPMaternal vitamin D status in pregnancy: a critical appraisal of current analytical data on maternal and neonatal outcomes. Hormones (Athens). 2015;14(2):224–31.